Zoledronate Inhibits Osteoclast Differentiation via Suppressing Vascular Endothelial Growth Factor Receptor 2 Expression. [electronic resource]
Producer: 20210107Description: 473-489 p. digitalISSN:- 1573-4927
- Animals
- Antibodies, Neutralizing -- immunology
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- metabolism
- Blood Donors
- CD11b Antigen -- metabolism
- Cell Differentiation -- drug effects
- Cells, Cultured
- Gene Expression -- drug effects
- Humans
- Leukocytes, Mononuclear -- metabolism
- Mice
- NFATC Transcription Factors -- genetics
- Osteoclasts -- cytology
- Vascular Endothelial Growth Factor Receptor-2 -- antagonists & inhibitors
- Zoledronic Acid -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.